


Searching News Database: Transkaryotic Therapies
HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
HSMN NewsFeed - 8 Nov 2006
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
HSMN NewsFeed - 8 Sep 2006
Shire Provides Update on U.S. Marketing Application of MESAVANCE(TM) (mesalamine) With MMX Technology
Shire Provides Update on U.S. Marketing Application of MESAVANCE(TM) (mesalamine) With MMX Technology
HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Additional items found! 65
Members Archive contains
65 additional stories matching:
Transkaryotic Therapies
(Password required)
Transkaryotic Therapies
(Password required)
